Inspection of Pacira Plant Prompts ‘Precautionary’ EU Recall of Cancer Drug DepoCyte

Drug Industry Daily
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has urged Pacira Pharmaceuticals’ cancer drug DepoCyte be recalled in certain EU countries, citing “manufacturing deficiencies” found at the company’s San Diego, Calif., facility.

To View This Article:


Subscribe To Drug Industry Daily